GM
PBE icon

GeoWealth Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

GeoWealth Management’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Sell
1,784
-93
-5% -$7.66K 0.01% 810
2026
Q1 		$149K Sell
1,877
-133
-7% -$10.8K 0.01% 765
2025
Q4 		$165K Sell
2,010
-611
-23% -$47.3K 0.01% 692
2025
Q3 		$183K Sell
2,621
-211
-7% -$14.3K 0.01% 701
2025
Q2 		$182K Sell
2,832
-160
-5% -$9.91K 0.01% 688
2025
Q1 		$190K Sell
2,992
-7,254
-71% -$488K 0.01% 673
2024
Q4 		$682K Sell
10,246
-2,320
-18% -$160K 0.02% 397
2024
Q3 		$877K Buy
12,566
+6,671
+113% +$462K 0.03% 331
2024
Q2 		$382K Buy
5,895
+54
+0.9% +$3.42K 0.02% 505
2024
Q1 		$378K Buy
5,841
+945
+19% +$61.5K 0.01% 508
2023
Q4 		$322K Buy
4,896
+604
+14% +$35.1K 0.03% 396
2023
Q3 		$245K Buy
4,292
+226
+6% +$13.8K 0.03% 263
2023
Q2 		$250K Buy
4,066
+1,353
+50% +$84.4K 0.03% 230
2023
Q1 		$171K Buy
2,713
+384
+16% +$24.7K 0.02% 217
2022
Q4 		$147K Sell
2,329
-584
-20% -$37K 0.02% 261
2022
Q3 		$172K Buy
+2,913
New +$179K 0.02% 249

Other funds holding PBE

YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
PIM
Penobscot Investment Management Boston, Massachusetts $1.46B AUM 32.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
NDSI
Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

GeoWealth Management's PBE Position: Q2 2026 in Review

GeoWealth Management reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 5% in Q2 2026, selling an estimated $7.66K and leaving 1,784 shares worth $160K. The position accounts for 0.01% of the portfolio, ranked #810.

GeoWealth Management first reported a position in PBE in Q3 2022 and has held it in 16 quarters since. The position peaked at $877K in Q3 2024. 31 funds tracked by Wall St. Rank hold PBE as of Q2 2026.

  • GeoWealth Management held 1,784 shares of Invesco Biotechnology & Genome ETF worth $160K as of Q2 2026.
  • GeoWealth Management sold 93 Invesco Biotechnology & Genome ETF shares in Q2 2026, an estimated $7.66K.
  • Invesco Biotechnology & Genome ETF made up 0.01% of GeoWealth Management's portfolio in Q2 2026, its #810 holding.
  • GeoWealth Management first reported a position in Invesco Biotechnology & Genome ETF in Q3 2022 and has held it in 16 quarters since.
  • GeoWealth Management's Invesco Biotechnology & Genome ETF position peaked at $877K in Q3 2024.
  • 31 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2026.

Based on GeoWealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.